{
  "emails": [
    {
      "from_address": "sarah.chen@maplewoodresearch.com",
      "to_addresses": [
        "alex.johnson@denalitx.com"
      ],
      "cc_addresses": [
        "maria.garcia@maplewoodresearch.com",
        "ben.carter@synergyclinical.com"
      ],
      "subject": "URGENT Notification: Temperature Excursion for DNL593/Placebo - Site 101",
      "timestamp": "2023-11-06T08:32:00Z",
      "body": "Dear Alex,\n\nThis is an urgent notification regarding a temperature excursion for the Investigational Product refrigerator at Site 101, Maplewood Clinical Research Center.\n\nThe excursion was noted this morning at 8:00 AM EST. The refrigerator stores all kits for the DNL593 study, including active drug and placebo.\n\nDetails:\n- Duration of excursion: Approximately 6 hours (from 1:45 AM to 7:45 AM EST).\n- Minimum Temperature Recorded: 1.2\u00b0C\n- Maximum Temperature Recorded: 9.5\u00b0C (briefly)\n- Standard Range: 2\u00b0C to 8\u00b0C\n\nI have attached the continuous temperature monitoring log for your review. All affected DNL593 and placebo kits have been identified and remain in the refrigerator, but are not being dispensed.\n\nPlease provide immediate guidance on the viability of the affected product and instructions on next steps.\n\nBest regards,\n\nDr. Sarah Chen\nInvestigational Drug Pharmacist\nMaplewood Clinical Research Center\n(555) 123-4567",
      "attachments": [
        "TempLog_Site101_20231106.pdf"
      ],
      "message_id": 9501,
      "in_reply_to": null
    },
    {
      "from_address": "alex.johnson@denalitx.com",
      "to_addresses": [
        "sarah.chen@maplewoodresearch.com",
        "david.lee@denalitx.com"
      ],
      "cc_addresses": [
        "maria.garcia@maplewoodresearch.com",
        "ben.carter@synergyclinical.com"
      ],
      "subject": "Re: URGENT Notification: Temperature Excursion for DNL593/Placebo - Site 101",
      "timestamp": "2023-11-06T09:15:00Z",
      "body": "Hi Sarah,\n\nThank you for the prompt and detailed notification. I have received the temperature log.\n\nPlease immediately quarantine all affected DNL593 and placebo kits. Label the stock clearly with \"QUARANTINED - DO NOT USE PENDING SPONSOR ASSESSMENT.\"\n\nI am looping in David Lee, our Clinical Supply Manager at Denali, to conduct a formal stability assessment based on the data you provided.\n\nDavid, can you please review the attached log from the previous email and advise on the viability of the product? Please let us know if you require any further information from the site.\n\nSarah, we will provide further instructions as soon as the assessment is complete. Please confirm once the product has been quarantined.\n\nBest regards,\n\nAlex Johnson\nClinical Research Associate\nDenali Therapeutics",
      "attachments": [],
      "message_id": 9502,
      "in_reply_to": 9501
    }
  ],
  "role_descriptions": [
    "alex.johnson@denalitx.com: Denali Therapeutics (Sponsor), Clinical Research Associate",
    "david.lee@denalitx.com: Denali Therapeutics (Sponsor), Clinical Supply Manager",
    "sarah.chen@maplewoodresearch.com: Maplewood Clinical Research Center (Site), Investigational Drug Pharmacist",
    "maria.garcia@maplewoodresearch.com: Maplewood Clinical Research Center (Site), Clinical Research Coordinator",
    "ben.carter@synergyclinical.com: Synergy Clinical (CRO), Project Manager"
  ],
  "description": "An urgent notification from a site pharmacist regarding a temperature excursion in the refrigerator storing the DNL593 and placebo. The thread shows Alex Johnson coordinating with Denali's clinical supply manager to determine if the product is still viable and providing instructions to the site to quarantine the affected stock."
}